CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-13 | JUNIUS DANIEL M Director | Option exercise | +1,279 | $283.59 | $363K | 5,987 |
| 2025-05-13 | JUNIUS DANIEL M Director | Sale | −2,683 | $506.41 | $1.4M | 3,304 |
| 2025-05-13 | JUNIUS DANIEL M Director | Option exercise · Non-Qualified Stock Option (right-to-buy) | −1,404 | 0 | ||
| 2025-05-13 | JUNIUS DANIEL M Director | Option exercise · Non-Qualified Stock Option (right-to-buy) | −1,279 | 0 | ||
| 2025-05-09 | Vandebroek Sophie V. Director | Option exercise | +1,279 | $283.59 | $363K | 2,446 |
| 2025-05-09 | Vandebroek Sophie V. Director | Sale | −1,279 | $491.34 | $628K | 1,167 |
| 2025-05-09 | Vandebroek Sophie V. Director | Option exercise · Non-Qualified Stock Option (right-to-buy) | −1,279 | 0 | ||
| 2025-05-07 | Vandebroek Sophie V. Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +600 | 600 | ||
| 2025-05-07 | Vandebroek Sophie V. Director | Grant or award · Restricted Stock Unit | +257 | 257 | ||
| 2025-05-07 | SZOSTAK M ANNE Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +600 | 600 | ||
| 2025-05-07 | SZOSTAK M ANNE Director | Grant or award · Restricted Stock Unit | +257 | 257 | ||
| 2025-05-07 | SAMAD SAM Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +600 | 600 | ||
| 2025-05-07 | SAMAD SAM Director | Grant or award · Deferred Stock Unit | +257 | 257 | ||
| 2025-05-07 | Kingsley Lawrence D Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +600 | 600 | ||
| 2025-05-07 | Kingsley Lawrence D Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +192 | 192 | ||
| 2025-05-07 | Kingsley Lawrence D Director | Grant or award · Restricted Stock Unit | +257 | 257 | ||
| 2025-05-07 | Kingsley Lawrence D Director | Grant or award · Restricted Stock Unit | +82 | 82 | ||
| 2025-05-07 | JUNIUS DANIEL M Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +600 | 600 | ||
| 2025-05-07 | JUNIUS DANIEL M Director | Grant or award · Restricted Stock Unit | +257 | 257 | ||
| 2025-05-07 | ESSIG STUART Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +600 | 600 |
Page 18 of 52 · 1,036 trades